No Data
Sanyou Lianzhong: Semi-Annual Report for 2026
Sanyou Lianzhong: Summary of the Semi-Annual Report for 2026
Sanyou Lianzhong (300932.SZ) reported its first-half results, with net profit attributable to shareholders reaching RMB 82.44 million, a year-on-year increase of 92.24%.
Sanyou Lianzhong (300932.SZ) released its 2026 semi-annual report. During the reporting period, the company achieved operating revenue of RMB 1.375 billion, a year-on-year increase of 19.29%. Net profit attributable to shareholders of the listed company amounted to RMB 82.4443 million, representing a year-on-year increase of 92.24%. Net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, reached RMB 83.7343 million, up 95.01% year on year.
Sanyou Lianzhong (300932.SZ): Repurchased 1.058% of Total Shares; Share Repurchase Program Completed
Gelonghui, August 10 — Sanyo Lianzhong (300932.SZ) announced that, as of the date of this disclosure, the share repurchase program has been fully implemented. The actual repurchase period ran from July 14, 2026, to August 7, 2026. During this period, the company cumulatively repurchased 4.74 million shares via centralized bidding transactions through its dedicated securities account for share repurchases, representing 1.0580% of the company’s current total share capital. The highest transaction price was RMB 9.95 per share, and the lowest was RMB 7.99 per share, with a total transaction value of RMB 40 million (excluding transaction fees). This repurchase complies with the company's share repurchase
Sanyou Lianzhong (300932.SZ): Repurchased a cumulative total of 4.7384 million shares of the company's stock.
Gelonghui, August 3 — Sanyou Lianzhong (300932.SZ) announced that, as of July 31, 2026, the company has repurchased a total of 4,738,400 shares through its dedicated securities account for share repurchases via centralized bidding transactions, representing 1.0573% of the company's current total share capital. The lowest transaction price was RMB 7.99 per share, and the highest was RMB 9.20 per share, with a total transaction amount of RMB 39,973,997.13 (excluding transaction fees). This repurchase complies with the company’s repurchase plan and applicable laws and regulations.
SAI-DA 1.0 | GEOTA Platform: Revolutionizing Drug R&D With Digital Computing Power
SHANGHAI, July 9, 2026 /PRNewswire/ -- Developing innovative drugs is no easy feat. For years, the industry has battled three major pain points: long cycles, staggering costs, and high failure rates.